TU9-27714-57017
3 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 937 / CA
- Registered
- 2021-11-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
HS4-28602-37776
Child or adolescent in my care · Female · 2022-06-30
Timeline
-
2021-02-25
Dose 1 — Moderna
-
2021-03-25
Dose 2 — Moderna
-
2021-11-27
Dose 3 — Moderna
-
2021-11-28
Registered in v-safe
- 2021-11-30
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-27
- 2022-01-01
- 2022-01-08
- 2022-02-26
- 2022-05-28
-
2022-11-27
Survey response — 12 months, dose 3MedDRA: Influenza, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu, congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Moderna | No |
| 2 | 2021-03-25 | Moderna | No |
| 3 | 2021-11-27 | Moderna | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: Flu, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release